These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25336895)

  • 1. The Comparative Genomics and Phylogenomics of Leishmania amazonensis Parasite.
    Tschoeke DA; Nunes GL; Jardim R; Lima J; Dumaresq AS; Gomes MR; de Mattos Pereira L; Loureiro DR; Stoco PH; de Matos Guedes HL; de Miranda AB; Ruiz J; Pitaluga A; Silva FP; Probst CM; Dickens NJ; Mottram JC; Grisard EC; Dávila AM
    Evol Bioinform Online; 2014; 10():131-53. PubMed ID: 25336895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
    Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
    Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of kDNA minicircle subclass relative abundance to differentiate between Leishmania (L.) infantum and Leishmania (L.) amazonensis.
    Ceccarelli M; Galluzzi L; Diotallevi A; Andreoni F; Fowler H; Petersen C; Vitale F; Magnani M
    Parasit Vectors; 2017 May; 10(1):239. PubMed ID: 28511704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmaniasis in Brazil: XII. Observations on cross-immunity in monkeys and man infected with Leishmania mexicana mexicana, L. m. amazonensis, L. braziliensis braziliensis, L. b. guyanensis and L. b. panamensis.
    Lainson R; Shaw JJ
    J Trop Med Hyg; 1977 Feb; 80(2):29-35. PubMed ID: 405504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITS1 PCR-RFLP Diagnosis and Characterization of Leishmania in Clinical Samples and Strains from Cases of Human Cutaneous Leishmaniasis in States of the Mexican Southeast.
    Monroy-Ostria A; Nasereddin A; Monteon VM; Guzmán-Bracho C; Jaffe CL
    Interdiscip Perspect Infect Dis; 2014; 2014():607287. PubMed ID: 25104958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genome sequence of Leishmania (Leishmania) amazonensis: functional annotation and extended analysis of gene models.
    Real F; Vidal RO; Carazzolle MF; Mondego JM; Costa GG; Herai RH; Würtele M; de Carvalho LM; Carmona e Ferreira R; Mortara RA; Barbiéri CL; Mieczkowski P; da Silveira JF; Briones MR; Pereira GA; Bahia D
    DNA Res; 2013 Dec; 20(6):567-81. PubMed ID: 23857904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmaniasis in Brazil: XV. Biochemical distinction of Leishmania mexicana amazonensis, L. braziliensis braziliensis and L. braziliensis guyanensis--aetiological agents of cutaneous leishmaniasis in the Amazon Basin of Brazil.
    Miles MA; Lainson R; Shaw JJ; Póvoa M; de Souza AA
    Trans R Soc Trop Med Hyg; 1981; 75(4):524-9. PubMed ID: 7324127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of
    Ceccarelli M; Diotallevi A; Buffi G; De Santi M; Fernández-Figueroa EA; Rangel-Escareño C; Muñoz-Montero SA; Becker I; Magnani M; Galluzzi L
    Microorganisms; 2020 May; 8(6):. PubMed ID: 32486117
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing the composition of the plasma membrane of Leishmania (Leishmania) infantum and L. (L.) amazonensis using label-free proteomics.
    Oliveira IHR; Figueiredo HCP; Rezende CP; Verano-Braga T; Melo-Braga MN; Reis Cunha JL; de Andrade HM
    Exp Parasitol; 2020 Nov; 218():107964. PubMed ID: 32822697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo.
    Coser EM; Ferreira BA; Branco N; Yamashiro-Kanashiro EH; Lindoso JAL; Coelho AC
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():91-98. PubMed ID: 33011651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa.
    Giarola NL; Silveira TS; Inacio JD; Vieira LP; Almeida-Amaral EE; Meyer-Fernandes JR
    Exp Parasitol; 2014 Nov; 146():25-33. PubMed ID: 25176449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
    Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipid degradation in Leishmania (Leishmania) amazonensis.
    Pillai AB; Xu W; Zhang O; Zhang K
    PLoS Negl Trop Dis; 2012; 6(12):e1944. PubMed ID: 23285302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoproteomic and bioinformatic approaches to identify secreted Leishmania amazonensis, L. braziliensis, and L. infantum proteins with specific reactivity using canine serum.
    Lima BS; Fialho LC; Pires SF; Tafuri WL; Andrade HM
    Vet Parasitol; 2016 Jun; 223():115-9. PubMed ID: 27198787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomics of canine-isolated Leishmania (Leishmania) amazonensis from an endemic focus of visceral leishmaniasis in Governador Valadares, southeastern Brazil.
    Valdivia HO; Almeida LV; Roatt BM; Reis-Cunha JL; Pereira AA; Gontijo C; Fujiwara RT; Reis AB; Sanders MJ; Cotton JA; Bartholomeu DC
    Sci Rep; 2017 Jan; 7():40804. PubMed ID: 28091623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental cutaneous leishmaniasis. IV. The humoral response of Cebus apella (Primates: Cebidae) to infections of Leishmania (Leishmania) amazonensis, L. (Viannia) lainsoni and L. (V.) braziliensis using the direct agglutination test.
    Garcez LM; Silveira FT; el Harith A; Lainson R; Shaw JJ
    Acta Trop; 1997 Oct; 68(1):65-76. PubMed ID: 9352003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive nitric oxide synthase-like enzyme in two species involved in cutaneous and mucocutaneous leishmaniasis.
    Furtado RR; Soares DC; Prado AF; Farias LHS; Da Silva BJM; Rodrigues APD; Silva EO
    Parasitol Int; 2021 Aug; 83():102347. PubMed ID: 33862253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocopherol biosynthesis in
    Balanco JMF; Sussmann RAC; Verdaguer IB; Gabriel HB; Kimura EA; Katzin AM
    FEBS Open Bio; 2019 Apr; 9(4):743-754. PubMed ID: 30984548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
    Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
    PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A focus of mucocutaneous leishmaniasis in Três Braços, Bahia, Brazil: characterization and identification of Leishmania stocks isolated from man and dogs.
    Cuba Cuba CA; Miles MA; Vexenat A; Barker DC; McMahon Pratt D; Butcher J; Barreto AC; Marsden PD
    Trans R Soc Trop Med Hyg; 1985; 79(4):500-7. PubMed ID: 3909556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.